Comorbidity and polypharmacy among women living with HIV in British Columbia.

Clicks: 266
ID: 16215
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #28 of 37 articles by views in aids (london, england)

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
To characterize comorbid disease and medication burden among women living with HIV (WLWH) in British Columbia (BC), Canada.We examined baseline data from 267 WLWH and 276 HIV-negative females, ≥19 years, enrolled in the Children and Women: Antiretrovirals and Markers of Aging (CARMA) cohort.Self-reported demographic, medical condition, medication, vitamin, and substance exposure data were collected at baseline CARMA study visits. We considered conditions with appropriate concomitant medications to be "treated". Wilcoxon rank-sum and Fisher's exact tests compared continuous and categorical variables between WLWH and HIV-negative women. Number of diagnoses, prescribed medications (excluding HIV/antiretrovirals), vitamins, and prevalence of depression/anxiety/panic disorder were compared using negative binomial and logistic regressions for continuous and binary variables respectively.WLWH were younger (median [IQR] 39.9 [33.6-46.9] vs 43.6 [31.8-54.6] years, p = 0.01), attained lower education (40.5% vs 69.6% college/university, p < 0.001), and more often currently smoked tobacco (47.9% vs 31.9%, p < 0.001), or had income <$15,000/year (49.0% vs 43.1%, p < 0.001). Although younger, and despite omitting HIV infection, WLWH had a greater number of diagnoses (IRR [95%CI] 1.58 [1.38-1.81], p <0.001), and more depression/anxiety/panic disorder versus controls (OR [95% CI], 1.86 [1.22-2.83], p = 0.004). Our model predicts that with mean BMI (26.3), WLWH and HIV-negative peers would have two comorbid diagnoses by age 30 and 60, respectively.WLWH living in BC have more comorbid illness earlier in life than their HIV-negative peers, and have very high rates of depression/anxiety/panic disorder. Addressing mental health and comorbid conditions is essential to improving health outcomes among WLWH.
Reference Key
donaldson2019comorbidityaids Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Donaldson, Mira A;Campbell, Amber R;Albert, Arianne Y;Borhani, Mahtab;Nesbitt, Ariel;Côté, Hélène C F;Maan, Evelyn J;Pick, Neora;Murray, Melanie C M;, ;
Journal aids (london, england)
Year 2019
DOI
10.1097/QAD.0000000000002353
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.